Endometriosis and cardiovascular disease

B Marchandot, A Curtiaud, K Matsushita… - … heart journal open, 2022 - academic.oup.com
Endometriosis is a chronic gynaecological disease affecting 1 in 10 reproductive-age
women. It is defined as the presence of endometrium-like tissue outside the uterus. Beyond …

[HTML][HTML] Carbohydrate antigen 125 in congestive heart failure: ready for clinical application?

R Feng, Z Zhang, Q Fan - Frontiers in Oncology, 2023 - frontiersin.org
Congestion is the permanent mechanism driving disease progression in patients with acute
heart failure (AHF) and also is an important treatment target. However, distinguishing …

[HTML][HTML] The biomarkers NT-proBNP and CA-125 are elevated in patients with idiopathic atrial fibrillation

EAMP Dudink, B Weijs, S Tull… - Journal of atrial …, 2018 - ncbi.nlm.nih.gov
Background Blood biomarkers related to AF could be useful to detect silent AF and to
develop stratified strategies for AF prevention. Previous studies identified markers that …

Carbohydrate antigen 125: a promising tool for risk stratification in heart diseases

F Falcão, FRA de Oliveira, MCFC da Silva… - Biomarkers in …, 2018 - Taylor & Francis
All patients with heart diseases should undergo risk stratification to predict those who are at
high risk for short-and long-term adverse outcomes. Carbohydrate antigen 125 (CA125) is a …

[HTML][HTML] Plasma carbohydrate antigen-125 for prediction of atrial fibrillation recurrence after radiofrequency catheter ablation

Q Wang, C Dang, H Liu, J Hui - BMC Cardiovascular Disorders, 2021 - Springer
Background Elevated plasma carbohydrate antigen-125 (CA-125) levels are strongly
associated with new-onset atrial fibrillation (AF) and heart failure, but the relationship …

Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women

H Sekiguchi, K Shimamoto, M Takano, M Kimura… - Heart, 2017 - heart.bmj.com
Objective Plasma cancer antigen (CA)-125 is a tumour marker recently shown to be
associated with systolic heart failure and new-onset atrial fibrillation (AF) after myocardial …

Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis

A Cheung, M Gong, R Bellanti… - Heart …, 2018 - heartasia.bmj.com
Background Cancer antigen-125 (Ca-125) is traditionally recognised as a tumour marker
and its role in cardiovascular diseases has been studied only in recent years. Whether Ca …

Higher cancer antigen 125 level is associated with the presence of permanent atrial fibrillation in systolic heart failure patients

H Kaya, A Zorlu, H Yucel, MA Tatlisu, T Kivrak… - Acta …, 2016 - Taylor & Francis
Introduction Atrial fibrillation (AF) is a common arrhythmia in heart failure (HF). Recent
studies have shown that serum cancer antigen-125 (CA-125) levels are elevated in HF, and …

[HTML][HTML] Impact of copd or asthma on the risk of atrial fibrillation: a systematic review and meta-analysis

Z Xue, S Guo, X Liu, J Ma, W Zhu, Y Zhou… - Frontiers in …, 2022 - frontiersin.org
Background: Respiratory diseases related to chronic pulmonary ventilation dysfunction are
mainly composed of chronic obstructive pulmonary disease (COPD) and asthma. Our meta …

[HTML][HTML] CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis

W Bulska-Będkowska, E Chełmecka… - Journal of Clinical …, 2019 - mdpi.com
(1) Background: Cancer antigen 125 (CA125) is a glycoprotein that is expressed by tissue
derived from coelomic epithelium in the pleura, peritoneum, pericardium. It has been shown …